No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Herceptin is a monoclonal antibody used to treat certain types of breast and gastric cancer. It is also used in the treatment of non-small cell lung cancer (NSCLC). Herceptin works by targeting the HER2 protein, which is found in higher levels in some types of cancer cells. This helps to slow down or stop the growth of cancer cells. Herceptin is used in combination with chemotherapy and other drugs to treat NSCLC.
Herceptin is a relatively new drug in the lung cancer market, but it has been shown to be effective in treating certain types of NSCLC. It is generally well-tolerated and has fewer side effects than other treatments. Herceptin is also used in combination with other drugs to treat metastatic NSCLC, which is when the cancer has spread to other parts of the body.
Herceptin is available in both generic and brand-name versions. It is typically administered intravenously in a hospital or clinic setting.
Some companies in the Herceptin market include Genentech, Roche, Merck, and Pfizer. Show Less Read more
